Table 1.
Clinical, biochemical, metabolic, and body composition characteristics of study participants.
| MHO | MUHO | p-Value | |
|---|---|---|---|
| N (male%) | 9 (55.6%) | 9 (44.4%) | |
| Age (years) | 31.3 ± 6.5 | 32 ± 8.8 | 0.86 |
| Weight (kg) | 128.2 ± 37.3 | 131.2 ± 26.5 | 0.85 |
| BMI (kg/m2) | 48.1 ± 13.18 | 48.66 ± 8.8 | 0.92 |
| Fat percentage | 52.2 ± 15.7 | 55.8 ± 11.3 | 0.61 |
| SBP (mm/Hg) | 122.6 ± 12.4 | 129 ± 5.7 | 0.20 |
| DBP (mm/Hg) | 74.3 ± 7.9 | 72.9 ± 4.9 | 0.67 |
| Fasting glucose (mmol/L) | 7.0 ± 2.4 | 9.6 ± 4.1 | 0.17 |
| Insulin (mIU/mL) | 15.0 ± 3.9 | 24.4 ± 10.9 | 0.05 |
| HOMA-IR | 4.6 ± 2.2 | 10.7 ± 7.5 | 0.05 |
| Total cholesterol (mmol/L) | 4.4 ± 1.0 | 4.4 ± 0.6 | 0.87 |
| Triglycerides (mmol/L) | 1.4 ± 0.8 | 2.0 ± 1.6 | 0.34 |
| HDL cholesterol (mmol/L) | 1.0 ± 0.3 | 0.8 ± 0.1 | 0.11 |
| LDL cholesterol (mmol/L) | 2.7 ± 0.8 | 2.7 ± 0.7 | 0.93 |
| Aspartate transaminase (IU/L) | 25.6 ± 13.9 | 25.8 ± 13.8 | 0.97 |
| Alanine transaminase (IU/L) | 41.0 ± 19.8 | 44.1 ± 28.0 | 0.80 |
| Alkaline phosphatase (IU/L) | 77.3 ± 24.0 | 92.9 ± 15.9 | 0.17 |
| Creatinine (mmol/L) | 72.5 ± 13.1 | 76.1 ± 23.3 | 0.71 |